Trial intelligence / Profile preview

Bioceramic Putty MTA vs Conventional MTA in Pulpotomy

NCT06219824Phase 3Not yet recruiting

Sponsor
Cairo University
Start
Nov 2024
Primary completion
Nov 2025
Countries
1
01

Overview

Phase 3, randomised trial (2 arms), sponsored by Cairo University. Primary endpoint: Primary Outcome (Clinical and Radiographic Success) at 1 week. Planned start Nov 2024; status: not yet recruiting.

Beyond the preview

Go deeper on NCT06219824.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06219824.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call